NR1H4 and metabolic dysfunction-associated steatotic liver disease: Recent studies show that FXR activation decreases intestinal lipid absorption and hepatic triglyceride levels to protect against NAFLD [46], and stimulating the FXR/BSEP pathway may promote the secretion of accumulated bile [47].